View in EDS

Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia.

Saved in:
Bibliographic Details
Title: Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia.
Authors: Rajagopal L; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA., Ryan C; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA., Elzokaky A; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA., Burstein ES; Acadia Pharmaceuticals Inc, San Diego, CA, 92130 USA., Meltzer HY; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: h-meltzer@northwestern.edu.
Source: Behavioural brain research [Behav Brain Res] 2022 Mar 26; Vol. 422, pp. 113710. Date of Electronic Publication: 2021 Dec 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 8004872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7549 (Electronic) Linking ISSN: 01664328 NLM ISO Abbreviation: Behav Brain Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34906610
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rajagopal+L%22">Rajagopal L</searchLink>; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+C%22">Ryan C</searchLink>; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA.<br /><searchLink fieldCode="AU" term="%22Elzokaky+A%22">Elzokaky A</searchLink>; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA.<br /><searchLink fieldCode="AU" term="%22Burstein+ES%22">Burstein ES</searchLink>; Acadia Pharmaceuticals Inc, San Diego, CA, 92130 USA.<br /><searchLink fieldCode="AU" term="%22Meltzer+HY%22">Meltzer HY</searchLink>; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: h-meltzer@northwestern.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228004872%22">Behavioural brain research</searchLink> [Behav Brain Res] 2022 Mar 26; Vol. 422, pp. 113710. <i>Date of Electronic Publication: </i>2021 Dec 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2FNorth-Holland+Biomedical+Press%22">Elsevier/North-Holland Biomedical Press </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8004872 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7549 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201664328%22">01664328 </searchLink><i>NLM ISO Abbreviation: </i>Behav Brain Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34906610
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bbr.2021.113710
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 113710
    Titles:
      – TitleFull: Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rajagopal L
      – PersonEntity:
          Name:
            NameFull: Ryan C
      – PersonEntity:
          Name:
            NameFull: Elzokaky A
      – PersonEntity:
          Name:
            NameFull: Burstein ES
      – PersonEntity:
          Name:
            NameFull: Meltzer HY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 03
              Text: 2022 Mar 26
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1872-7549
          Numbering:
            – Type: volume
              Value: 422
          Titles:
            – TitleFull: Behavioural brain research
              Type: main
ResultId 1